Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GVHD - Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT00032292
What this trial is testing

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Facet Biotech 34
Early research (Phase 1)Study completedNCT00760981
What this trial is testing

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
David Miklos 15
Not applicableStudy completedNCT07048730
What this trial is testing

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

Who this might be right for
Acute Leukemia
University Hospital, Bordeaux 51
Not applicableUnknownNCT02352064
What this trial is testing

Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)

Who this might be right for
Chronic Graft Versus Host Disease
University Hospital, Caen 26
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Large-scale testing (Phase 3)Ended earlyNCT05263999
What this trial is testing

Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Who this might be right for
Graft Versus Host DiseaseGVHDAcute-graft-versus-host Disease+2 more
Equillium 158
Testing effectiveness (Phase 2)Ended earlyNCT02737306
What this trial is testing

Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation

Who this might be right for
Graft Vs Host Disease
CytoDyn, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT02144025
What this trial is testing

Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT

Who this might be right for
Graft-Versus-Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 21
Testing effectiveness (Phase 2)Ended earlyNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 2
Testing effectiveness (Phase 2)Study completedNCT01680965
What this trial is testing

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 44
Early research (Phase 1)Study completedNCT05673876
What this trial is testing

Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Acute Graft-versus-host Disease
Genentech, Inc. 7
Early research (Phase 1)WithdrawnNCT02561520
What this trial is testing

Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD

Who this might be right for
Graft-versus-host Disease
Ladan Espandar
Large-scale testing (Phase 3)UnknownNCT06000982
What this trial is testing

Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

Who this might be right for
GVHD
Shanghai Jiao Tong University School of Medicine 138
Testing effectiveness (Phase 2)Study completedNCT00343785
What this trial is testing

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Who this might be right for
Aplastic Anemia
Fred Hutchinson Cancer Center 21
Post-approval studies (Phase 4)UnknownNCT05021276
What this trial is testing

Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 50
Large-scale testing (Phase 3)Ended earlyNCT02411084
What this trial is testing

Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD

Who this might be right for
Graft vs Host Disease
Adienne SA 36
Large-scale testing (Phase 3)Study completedNCT00179855
What this trial is testing

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseCancerStem Cell Transplantation
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Not applicableUnknownNCT02044185
What this trial is testing

Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-host Disease
Seoul St. Mary's Hospital 100
Next Page